GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) » Definitions » Market Cap

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Market Cap : ¥391.1 Mil (As of Jun. 10, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guangdong Taiantang Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Guangdong Taiantang Pharmaceutical Co's share price for the quarter that ended in Mar. 2024 was ¥1.24. Guangdong Taiantang Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 766.8 Mil. Therefore, Guangdong Taiantang Pharmaceutical Co's market cap for the quarter that ended in Mar. 2024 was ¥950.8 Mil.

Guangdong Taiantang Pharmaceutical Co's quarterly market cap declined from Sep. 2023 (¥2,430.7 Mil) to Dec. 2023 (¥1,817.3 Mil) and declined from Dec. 2023 (¥1,817.3 Mil) to Mar. 2024 (¥950.8 Mil).

Guangdong Taiantang Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥5,720.1 Mil) to Dec. 2022 (¥3,350.8 Mil) and declined from Dec. 2022 (¥3,350.8 Mil) to Dec. 2023 (¥1,817.3 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guangdong Taiantang Pharmaceutical Co's Enterprise Value for Today is ¥1,546.4 Mil.


Guangdong Taiantang Pharmaceutical Co Market Cap Historical Data

The historical data trend for Guangdong Taiantang Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taiantang Pharmaceutical Co Market Cap Chart

Guangdong Taiantang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,519.49 3,182.11 5,720.13 3,350.80 1,817.25

Guangdong Taiantang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,760.38 1,556.55 2,430.67 1,817.25 950.80

Competitive Comparison of Guangdong Taiantang Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Guangdong Taiantang Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Taiantang Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangdong Taiantang Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Guangdong Taiantang Pharmaceutical Co's Market Cap falls into.



Guangdong Taiantang Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Guangdong Taiantang Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥2.37*766.773
=¥1,817.3

Guangdong Taiantang Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥1.24*766.773
=¥950.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Taiantang Pharmaceutical Co  (SZSE:002433) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Guangdong Taiantang Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Guangdong Taiantang Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Business Description

Traded in Other Exchanges
N/A
Address
No. 888 North Sichuan Road, 25th Floor, Haitai International Building, Hongkou District, Shanghai, CHN, 200080
Guangdong Taiantang Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, manufacture and sale of high-effect skin-drugs.
Executives
Ke Shao Fang Directors, executives
Hu Qing Guang Director
Song Xiu Qing Director
Ke Shu Quan Director

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Headlines

No Headlines